J0572 Bupren/nal up to 3mg bupreno

Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine

Medically Unlikely Edits (effective October 1, 2026)

Medicare pricing for J0572

Physician Fee Schedule (CY 2026, RVU26D)

Status E: excluded from the PFS by regulation.

Payer policies and prior authorization for J0572

0 of 2 payer prior-auth lists that name J0572 require prior authorization or set conditions.

Payer coverage policies that name J0572

J0572 appears in 2 coverage policies from Aetna.

PayerPolicyRole in policyReviewedDocument
AetnaExtended-Release Buprenorphine Injectables (0910)listed, no stanceDec 30, 2025payer document
AetnaInjectable Medications (0020)listed, no stance (range J0278-J2543)Mar 5, 2026payer document

Recent prior-auth changes

  • Apr 1, 2025: PA removed, UnitedHealthcare
  • Mar 1, 2025: PA added, UnitedHealthcare
  • Jan 1, 2025: PA removed, UnitedHealthcare

Medicaid fee-for-service

Prior authorization required or conditional in VT.

  • AZ: $3.65 (outpatient_hospital), effective Oct 1, 2023
  • IN: $0.54 (professional, Advanced Practice Nurse (85%), non-facility), effective Jul 1, 2025
  • KS: $1.12 (default), effective Oct 1, 2026
  • MS: $2.48 (comprehensive), effective Jul 1, 2026
  • OH: $9.89 (provider_administered_drugs), effective Apr 1, 2022
  • OK: $1.14 (physician, non-facility), effective Jul 1, 2026
  • VA: $4.34 (medical), effective Apr 1, 2017
  • VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
  • WA: $0.43 (professional_administered_drugs), effective Jul 1, 2026
  • WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.